Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis.
Barriga FM, Tsanov KM, Ho YJ, Sohail N, Zhang A, Baslan T, Wuest AN, Del Priore I, Meskauskaite B, Livshits G, Alonso-Curbelo D, Simon J, Chaves-Perez A, Bar-Sagi D, Iacobuzio-Donahue CA, Notta F, Chaligne R, Sharma R, Pe'er D, Lowe SW
Nat Cancer. 2022 Nov;3(11):1367-1385. doi: 10.1038/s43018-022-00443-5. Epub 2022 Nov 7.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
195282pFB2Bicistronic DTR and Puromycin resistance for positive/negative selection
195283pFB2ABicistronic DTR and Hygromycin resistance for positive/negative selection
195284pFB2BBicistronic HSV-TK and Puromycin resistance for positive/negative selection
195285pFB2CBicistronic HSV-TK and Hygromycin resistance for positive/negative selection
195286pFB2DBicistronic DTR-EGFP fusion and Puromycin resistance for positive/negative selection
195288pFB2EBicistronic HSV-TK-EGFP fusion and Puromycin resistance for positive/negative selection
195289pFB2FBicistronic HSV-TK and mScarlet resistance for positive/negative selection
195290pFB2GBicistronic HSV-TK and mTagBFP resistance for positive/negative selection

Antibodies from Article